Goldman Sachs Downgrades Laboratory Corporation of America (LH) to Buy

Goldman Sachs analyst Patrick Donnelly downgraded Laboratory Corporation of America (NYSE: LH) from Conviction Buy to Buy with a price target of $180.00 (from $190.00).

The analyst views the company as a Top Pick in the Lab industry but removes from the Conviction Buy List as it has underperformed the broad index since being added back in January 2018.

For an analyst ratings summary and ratings history on Laboratory Corporation of America click here. For more ratings news on Laboratory Corporation of America click here.

Shares of Laboratory Corporation of America closed at $161.81 yesterday.

You May Also Be Interested In

• Onto Innovation Inc. (ONTO) PT Raised to $450 at Oppenheimer
• Grupo Aeroportuario del Centro (OMAB:MM) (OMAB) PT Raised to Peso235 at Scotiabank
• Labcorp makes RNA-based colorectal cancer home test available nationwide